Liposome-CD4 data

The Houston company said its Liposome-CD4 compound demonstrated anti-viral activity against HIV in vitro as measured by p24 levels for 16 days. The data will be submitted to a peer review journal, SHM said.

The company also said it will not proceed with development of an ovarian cancer marker. SHM said the marker could be identified in tissue samples using an antibody test, but could not be consistently detected in serum samples. ...